Dr. Jenna Carpenter, D.O. Internal Medicine - Critical Care Medicine Medicare: May Accept Medicare Assignments Practice Location: 2525 Us Highway 431, Pulmonary And Sleep Associates, Suite 210, Boaz, AL 35957 Phone: 256-840-4653 Fax: 256-840-3182 |
News Archive
First-of-its-kind research by the Innovation Institute at Henry Ford Hospital shows promise for developing a method of clearly identifying cancerous tissue during surgery on one of the most common and deadliest types of brain tumor.
Cannabis Science Inc. (NASD OTCBB: CBIS) an emerging pharmaceutical cannabis company, is pleased to report that it will be featured on two broadcast radio shows beginning tomorrow with Stu Taylor and the "Equity Strategies Show". Mr. Taylor will interview Cannabis Science Inc., President & CEO, Dr. Robert Melamede Ph.D., discussing the Company's strategies with its FDA Drug approval programs, the Company's progress to date with its critical drug release programs, and future planning for subsequent drug releases through additional Federal and State government agencies.
For decades, patients with Parkinson's disease (PD) have had the same experience. Their hands start to shake uncontrollably, their limbs become rigid and they lose their balance. Years before those movement problems set in, many begin struggling with fainting, incontinence, sexual dysfunction, anxiety and depression. Many patients are still treated with a 42-year-old drug called L-DOPA, which temporarily staves off symptoms but can itself cause heart arrhythmias, stomach bleeding and hallucinations.
According to a new report, cardiac surgery can be safely performed in octogenarians and may improve their life expectancy.
InVivo Therapeutics Holdings Corp. (NVIV) announced today that it has received conditional approval from the Food and Drug Administration for proposed changes to the protocol and supporting documents for the safety trial of its first investigational product, a degradable polymer scaffold for spinal cord injury.
› Verified 7 days ago